{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:08Z","timestamp":1786979768527,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00210-025-04278-6","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:57:34Z","timestamp":1747997854000},"page":"15923-15932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paroxetine attenuated liver fibrosis in liver of bile duct ligated rats: role of P2X4 purinoreceptor"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6684-333X","authenticated-orcid":false,"given":"Alireza","family":"Karimollah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Dabaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Sadat","family":"Nabavinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Hasanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameneh","family":"Khodarahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"4278_CR1","doi-asserted-by":"crossref","first-page":"122642","DOI":"10.1016\/j.lfs.2024.122642","volume":"347","author":"FEM Ali","year":"2024","unstructured":"Ali FEM, Abdel-Reheim MA, Hassanein EHM, Abd El-Aziz MF, Althagafy HS, Badran KLA (2024) Exploring the potential of drug repurposing for liver diseases: A comprehensive study. Life Sci 347:122642","journal-title":"Life Sci"},{"key":"4278_CR2","doi-asserted-by":"crossref","first-page":"17270","DOI":"10.3390\/ijms242417270","volume":"24","author":"AS Alonazi","year":"2023","unstructured":"Alonazi AS, Bin AF, Dayel DA, Albuaijan AS, Osfur B, Hakami FM, Alzayed SS, Almotairi AR, Khan MR, Alharbi HM, Ali RA (2023) Cardioprotective effects of the GRK2 inhibitor paroxetine on isoproterenol-induced cardiac remodeling by modulating NF-\u03baB mediated prohypertrophic and profibrotic gene expression. Int J Mol Sci 24:17270","journal-title":"Int J Mol Sci"},{"key":"4278_CR3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.euroneuro.2007.03.001","volume":"17","author":"PC Casarotto","year":"2007","unstructured":"Casarotto PC, Andreatini R (2007) Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. Eur Neuropsychopharmacol 17:735\u2013742","journal-title":"Eur Neuropsychopharmacol"},{"key":"4278_CR4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.psyneuen.2017.10.009","volume":"87","author":"C-Y Chen","year":"2018","unstructured":"Chen C-Y, Yeh Y-W, Kuo S-C, Liang C-S, Ho P-S, Huang C-C, Yen C-H, Shyu J-F, Ru-Band Lu, Huang S-Y (2018a) Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder. Psychoneuroendocrinology 87:108\u2013118","journal-title":"Psychoneuroendocrinology"},{"key":"4278_CR5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/jvh.12884","volume":"25","author":"JY Chen","year":"2018","unstructured":"Chen JY, Ren Y, Yan P, Belina ME, Chung RT, Butt AA (2018b) Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: results from ERCHIVES. J Viral Hepatitis 25:825\u2013833","journal-title":"J Viral Hepatitis"},{"key":"4278_CR6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.17305\/bb.2023.9000","volume":"23","author":"C Chi","year":"2023","unstructured":"Chi C, Liang X, Cui T, Gao X, Liu R, Yin C (2023) SKIL\/SnoN attenuates TGF-\u03b21\/SMAD signaling-dependent collagen synthesis in hepatic fibrosis. Biomol Biomed 23:1014","journal-title":"Biomol Biomed"},{"key":"4278_CR7","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.bbadis.2018.09.027","volume":"1864","author":"M Cruces-Sande","year":"2018","unstructured":"Cruces-Sande M, Vila-Bedmar R, Arcones AC, Gonzalez-Rodriguez A, Rada P, Gutierrez-de-Juan V, Vargas-Castrillon J, Iruzubieta P, Sanchez-Gonzalez C, Formentini L (2018) Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans. Biochim Biophys Acta BBA Mol Basis Disease 1864:3655\u201367","journal-title":"Biochim Biophys Acta BBA Mol Basis Disease"},{"key":"4278_CR8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.intimp.2015.02.029","volume":"25","author":"H Durairaj","year":"2015","unstructured":"Durairaj H, Steury MD, Parameswaran N (2015) Paroxetine differentially modulates LPS-induced TNF\u03b1 and IL-6 production in mouse macrophages. Int Immunopharmacol 25:485\u2013492","journal-title":"Int Immunopharmacol"},{"key":"4278_CR9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S0007114518001095","volume":"120","author":"A Eshaghian","year":"2018","unstructured":"Eshaghian A, Khodarahmi A, Safari F, Binesh F, Moradi A (2018) Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats. Br J Nutr 120:393\u2013403","journal-title":"Br J Nutr"},{"key":"4278_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41401-023-01149-9","volume":"45","author":"R-H Fang","year":"2024","unstructured":"Fang R-H, Zhou Z-W, Chu R, Guan Q-Y, He F, Ge M-l, Guo P-P, Hua-xun Wu, Yao L-l, Wei W (2024) G protein-coupled receptor kinase 2 as a novel therapeutic target for gland fibrosis of Sj\u00f6gren\u2019s syndrome. Acta Pharmacol Sin 45:1\u201314","journal-title":"Acta Pharmacol Sin"},{"key":"4278_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11302-015-9466-3","volume":"11","author":"D Gentile","year":"2015","unstructured":"Gentile D, Natale M, Lazzerini PE, Capecchi PL, Laghi-Pasini F (2015) The role of P2X 7 receptors in tissue fibrosis: a brief review. Purinergic Signal 11:435\u2013440","journal-title":"Purinergic Signal"},{"key":"4278_CR12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jhep.2018.05.020","volume":"69","author":"Le Guilcher","year":"2018","unstructured":"Guilcher Le, Camille IG, Dellis O, Cauchois F, Tebbi A, Doignon I, Guettier C, Julien B, Tordjmann T (2018) The P2X4 purinergic receptor regulates hepatic myofibroblast activation during liver fibrogenesis. J Hepatol 69:644\u2013653","journal-title":"J Hepatol"},{"key":"4278_CR13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3892\/etm.2015.2663","volume":"10","author":"J Han","year":"2015","unstructured":"Han J, Wang LU, Bian H, Zhou X, Ruan C (2015) Effects of paroxetine on spatial memory function and protein kinase C expression in a rat model of depression. Exp Ther Med 10:1489\u20131492","journal-title":"Exp Ther Med"},{"key":"4278_CR14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","volume":"180","author":"B Hinz","year":"2012","unstructured":"Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouli\u00e8re A, Varga J, De Wever O, Mareel M, Gabbiani G (2012) Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 180:1340\u20131355","journal-title":"Am J Pathol"},{"key":"4278_CR15","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/0269881113494938","volume":"27","author":"TM Hu","year":"2013","unstructured":"Hu TM, Subeq YM, Yang FL, Hsu BG, Lin NT, Lee RuP (2013) The use of a selective serotonin reuptake inhibitor decreases heavy alcohol exposure-induced inflammatory response and tissue damage in rats. J Psychopharmacol 27:940\u2013946","journal-title":"J Psychopharmacol"},{"key":"4278_CR16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12929-022-00850-x","volume":"29","author":"C-T Hung","year":"2022","unstructured":"Hung C-T, Tsai Y-W, Yu-Shuo Wu, Yeh C-F, Yang K-C (2022) The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications. J Biomed Sci 29:63","journal-title":"J Biomed Sci"},{"key":"4278_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10616-016-9948-3","volume":"69","author":"A Inoue","year":"2017","unstructured":"Inoue A, Obayashi K, Sonoda Y, Nakamura A, Ueno T, Kuhara S, Tashiro K (2017) Regulation of matrix metalloproteinase-1 and alpha-smooth muscle actin expression by interleukin-1 alpha and tumour necrosis factor alpha in hepatic stellate cells. Cytotechnology 69:461\u2013468","journal-title":"Cytotechnology"},{"key":"4278_CR18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2022.12.025","volume":"642","author":"T Iwanaga","year":"2023","unstructured":"Iwanaga T, Chiba T, Nakamura M, Kaneko T, Ao J, Qiang Na, Ma Y, Zhang J, Kogure T, Yumita S (2023) Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-\u03b2\/Smad pathway suppression in hepatic stellate cells. Biochem Biophys Res Commun 642:192\u2013200","journal-title":"Biochem Biophys Res Commun"},{"key":"4278_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0043-118666","volume":"50","author":"S Kakino","year":"2018","unstructured":"Kakino S, Ohki T, Nakayama H, Yuan X, Otabe S, Hashinaga T, Wada N, Kurita Y, Tanaka K, Hara K (2018) Pivotal role of TNF-\u03b1 in the development and progression of nonalcoholic fatty liver disease in a murine model. Horm Metab Res 50:80\u201387","journal-title":"Horm Metab Res"},{"key":"4278_CR20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645834","volume":"12","author":"JM Kanellopoulos","year":"2021","unstructured":"Kanellopoulos JM, Almeida-da-Silva CLC, Boudinot SR, Ojcius DM (2021) Structural and functional features of the P2X4 receptor: an immunological perspective. Front Immunol 12:645834","journal-title":"Front Immunol"},{"key":"4278_CR21","doi-asserted-by":"crossref","unstructured":"Kiliaris G, El Agha E (2024) InfluenZing Lung Fibrosis: Reinforcing Endothelial Surface Expression of S1PR1 to Attenuate Post\u2013Acute Respiratory Distress Syndrome Lung Remodeling. In: 89\u201390. American Thoracic Society","DOI":"10.1165\/rcmb.2023-0372ED"},{"key":"4278_CR22","volume":"12","author":"N Li","year":"2022","unstructured":"Li N, Shan S, Li X-Q, Chen T-T, Qi M, Zhang S-N, Wang Z-Y, Zhang L-L, Wei W, Sun W-Y (2022a) G protein-coupled receptor kinase 2 as novel therapeutic target in fibrotic diseases. Front Immunol 12:822345","journal-title":"Front Immunol"},{"key":"4278_CR23","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.7150\/ijbs.75876","volume":"18","author":"Y Li","year":"2022","unstructured":"Li Y, Zhao J, Yin Y, Li Ke, Zhang C, Zheng Y (2022b) The role of IL-6 in fibrotic diseases: molecular and cellular mechanisms. Int J Biol Sci 18:5405","journal-title":"Int J Biol Sci"},{"key":"4278_CR24","volume":"113","author":"ZX Li","year":"2022","unstructured":"Li ZX, Sheng XD, Wang YL, Lv XW (2022c) Blocking P2X4 purinergic receptor attenuates alcohol-related liver fibrosis by inhibiting hepatic stellate cell activation through PI3K\/AKT signaling pathway. Int Immunopharmacol 113:109326","journal-title":"Int Immunopharmacol"},{"key":"4278_CR25","volume":"221","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun M, Liu W, Feng F, Li X, Jin C, Zhang Y, Wang J (2024) Deficiency of purinergic P2X4 receptor alleviates experimental autoimmune hepatitis in mice. Biochem Pharmacol 221:116033","journal-title":"Biochem Pharmacol"},{"key":"4278_CR26","unstructured":"Malubay, Sienna Marie Arenas (2006) Modulation of the Serotonin Reuptake Transporter in RAW264. 7 Macrophages"},{"key":"4278_CR27","doi-asserted-by":"crossref","unstructured":"Maroteaux, Luc, and Laurent Monassier (2021) 5-HT2B Receptors: from molecular biology to clinical applications (Springer Nature)","DOI":"10.1007\/978-3-030-55920-5"},{"key":"4278_CR28","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.3390\/ijms25179447","volume":"25","author":"E Mata-Mart\u00ednez","year":"2024","unstructured":"Mata-Mart\u00ednez E, Ram\u00edrez-Ledesma MG, V\u00e1zquez-Victorio G, Hern\u00e1ndez-Mu\u00f1oz R, D\u00edaz-Mu\u00f1oz M, V\u00e1zquez-Cuevas FG (2024) Purinergic signaling in non-parenchymal liver cells. Int J Mol Sci 25:9447","journal-title":"Int J Mol Sci"},{"key":"4278_CR29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/chemse\/bjr011","volume":"36","author":"CM Mathes","year":"2011","unstructured":"Mathes CM, Spector AC (2011) The selective serotonin reuptake inhibitor paroxetine does not alter consummatory concentration-dependent licking of prototypical taste stimuli by rats. Chem Senses 36:515\u2013526","journal-title":"Chem Senses"},{"key":"4278_CR30","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40262-014-0187-5","volume":"53","author":"MC Mauri","year":"2014","unstructured":"Mauri MC, Fiorentini A, Paletta S, Altamura AC (2014) Pharmacokinetics of antidepressants in patients with hepatic impairment. Clin Pharmacokinet 53:1069\u20131081","journal-title":"Clin Pharmacokinet"},{"key":"4278_CR31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41420-022-01109-y","volume":"8","author":"W Mu","year":"2022","unstructured":"Mu W, Guang Xu, Wei Z, Wang Z, Qin Q, Lin Li, Ren L, Liu T, Fang Z, Yang Y (2022) The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicity. Cell Death Discovery 8:313","journal-title":"Cell Death Discovery"},{"key":"4278_CR32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2019.01.008","volume":"1866","author":"A Navarro-Corcuera","year":"2019","unstructured":"Navarro-Corcuera A, L\u00f3pez-Zabalza MJ, Mart\u00ednez-Irujo JJ, \u00c1lvarez-Sola G, \u00c1vila MA, Iraburu MJ, Ansorena E, Montiel-Duarte C (2019) Role of AGAP2 in the profibrogenic effects induced by TGF\u03b2 in LX-2 hepatic stellate cells. Biochimica et Biophysica Acta BBA Mol Cell Res 1866:673\u201385","journal-title":"Biochimica et Biophysica Acta BBA Mol Cell Res"},{"key":"4278_CR33","doi-asserted-by":"crossref","first-page":"1145070","DOI":"10.3389\/fimmu.2023.1145070","volume":"14","author":"L Ning","year":"2023","unstructured":"Ning L, Wang X, Xuan B, Ma Y, Yan Y, Gao Z, Tong T, Cui Z, Chen H, Li X (2023) Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine. Front Immunol 14:1145070","journal-title":"Front Immunol"},{"key":"4278_CR34","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/j.1572-0241.2001.04060.x","volume":"96","author":"M Odeh","year":"2001","unstructured":"Odeh M, Misselevech I, Boss JH, Oliven A (2001) Severe hepatotoxicity with jaundice associated with paroxetine. Off J Am College Gastroenterol ACG 96:2494\u201396","journal-title":"Off J Am College Gastroenterol ACG"},{"key":"4278_CR35","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1007\/s00210-023-02669-1","volume":"396","author":"HT \u00d6nal","year":"2023","unstructured":"\u00d6nal HT, Yetkin D, Ayaz F (2023) Paroxetine\u2019s effect on the proinflammatory cytokine stimulation and intracellular signaling pathways in J774. 2 cells. Naunyn Schmiedebergs Arch Pharmacol 396:3327\u20133335","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4278_CR36","doi-asserted-by":"crossref","first-page":"e65251","DOI":"10.1371\/journal.pone.0065251","volume":"8","author":"Y Osawa","year":"2013","unstructured":"Osawa Y, Hoshi M, Yasuda I, Saibara T, Moriwaki H, Kozawa O (2013) Tumor necrosis factor-\u03b1 promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PLoS ONE 8:e65251","journal-title":"PLoS ONE"},{"key":"4278_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Jane Escott K, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discover 18:41\u201358","journal-title":"Nat Rev Drug Discover"},{"key":"4278_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cbi.2018.05.002","volume":"289","author":"A Ramadan","year":"2018","unstructured":"Ramadan A, Afifi N, Yassin NZ, Abdel-Rahman RF, Abd El-Rahman SSA, Fayed HM (2018) Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats. Chem Biol Interact 289:109\u201318","journal-title":"Chem Biol Interact"},{"key":"4278_CR39","doi-asserted-by":"crossref","first-page":"e0153118","DOI":"10.1371\/journal.pone.0153118","volume":"11","author":"S Robert","year":"2016","unstructured":"Robert S, Gicquel T, Bodin A, Lagente V, Boichot E (2016) Characterization of the MMP\/TIMP imbalance and collagen production induced by IL-1\u03b2 or TNF-\u03b1 release from human hepatic stellate cells. PLoS ONE 11:e0153118","journal-title":"PLoS ONE"},{"key":"4278_CR40","doi-asserted-by":"crossref","first-page":"101390","DOI":"10.1016\/j.jceh.2024.101390","volume":"14","author":"S Sahoo","year":"2024","unstructured":"Sahoo S, Mishra E, Premkumar M (2024) Antidepressants in people with chronic liver disease and depression: when are they warranted and how to choose the suitable one? J Clin Exp Hepatol 14:101390","journal-title":"J Clin Exp Hepatol"},{"key":"4278_CR41","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.ajpath.2016.06.003","volume":"186","author":"K Sato","year":"2016","unstructured":"Sato K, Hall C, Glaser S, Francis H, Meng F, Alpini G (2016) Pathogenesis of Kupffer cells in cholestatic liver injury. Am J Pathol 186:2238\u20132247","journal-title":"Am J Pathol"},{"key":"4278_CR42","doi-asserted-by":"crossref","first-page":"874375","DOI":"10.3389\/fphar.2022.874375","volume":"13","author":"Y Takenaka","year":"2022","unstructured":"Takenaka Y, Tanaka R, Kitabatake K, Kuramochi K, Aoki S, Tsukimoto M (2022) Profiling differential effects of 5 selective serotonin reuptake inhibitors on TLRs-dependent and-independent IL-6 production in immune cells identifies fluoxetine as preferred anti-inflammatory drug candidate. Front Pharmacol 13:874375","journal-title":"Front Pharmacol"},{"key":"4278_CR43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.24388","volume":"54","author":"N Tarrats","year":"2011","unstructured":"Tarrats N, Moles A, Morales A, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC, Mar\u00ed M (2011) Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis. Hepatology 54:319\u2013327","journal-title":"Hepatology"},{"key":"4278_CR44","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3389\/fimmu.2018.02948","volume":"9","author":"E Triantafyllou","year":"2018","unstructured":"Triantafyllou E, Woollard KJ, McPhail MJW, Antoniades CG, Possamai LA (2018) The role of monocytes and macrophages in acute and acute-on-chronic liver failure. Front Immunol 9:2948","journal-title":"Front Immunol"},{"key":"4278_CR45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","volume":"26","author":"RJ Tynan","year":"2012","unstructured":"Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR (2012) A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 26:469\u2013479","journal-title":"Brain Behav Immun"},{"key":"4278_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-025-10067-w","volume":"21","author":"H Ulrich","year":"2024","unstructured":"Ulrich H, Glaser T, Thomas AP (2024) Purinergic signaling in liver disease: calcium signaling and induction of inflammation. Purinergic Signal 21:1\u201313","journal-title":"Purinergic Signal"},{"key":"4278_CR47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11302-019-09680-3","volume":"15","author":"E Vel\u00e1zquez-Miranda","year":"2019","unstructured":"Vel\u00e1zquez-Miranda E, D\u00edaz-Mu\u00f1oz M, V\u00e1zquez-Cuevas FG (2019) Purinergic signaling in hepatic disease. Purinergic Signal 15:477\u2013489","journal-title":"Purinergic Signal"},{"key":"4278_CR48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","volume":"171","author":"CS Voican","year":"2014","unstructured":"Voican CS, Corruble E, Naveau S, Perlemuter G (2014) Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry 171:404\u2013415","journal-title":"Am J Psychiatry"},{"key":"4278_CR49","doi-asserted-by":"crossref","first-page":"100165","DOI":"10.1016\/j.jhepr.2020.100165","volume":"2","author":"P Wang","year":"2020","unstructured":"Wang P, Jia J, Zhang D (2020) Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities. JHEP Reports 2:100165","journal-title":"JHEP Reports"},{"key":"4278_CR50","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1073\/pnas.1010030108","volume":"108","author":"A Yarilina","year":"2011","unstructured":"Yarilina A, Kai Xu, Chen J, Ivashkiv LB (2011) TNF activates calcium\u2013nuclear factor of activated T cells (NFAT) c1 signaling pathways in human macrophages. Proc Natl Acad Sci 108:1573\u20131578","journal-title":"Proc Natl Acad Sci"},{"key":"4278_CR51","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1177\/0960327111400106","volume":"30","author":"A Zandieh","year":"2011","unstructured":"Zandieh A, Payabvash S, Pasalar P, Morteza A, Zandieh B, Tavangar SM, Dehpour AR (2011) Gadolinium chloride, a Kupffer cell inhibitor, attenuates hepatic injury in a rat model of chronic cholestasis. Hum Exp Toxicol 30:1804\u20131810","journal-title":"Hum Exp Toxicol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04278-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:13:32Z","timestamp":1761304412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04278-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4278"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04278-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Research Ethics Committee of Shahid Sadoughi University of Medical Sciences (IR.SSU.AEC.1401.019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}